Ipca Laboratories Ltd. | IPCALAB | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Revenue
Revenue
32,10632,83637,73246,48754,200
Cost of revenue
Cost of revenue
-11,102-11,248-12,397-16,441-17,283
Gross Profit
Gross Profit
21,005
21,588
25,335
30,046
36,917
Sales, general & ad...
Sales, general and administrative
-16,557-17,041-18,416-20,979-21,473
Depreciation
Depreciation and amortization
-1,730-1,777-1,824-2,105-2,092
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
00000
Operating income
Operating income EBIT
2,718
2,770
5,095
6,962
13,352
 
      
Profit before tax
Profit before tax
2,7032,9485,4837,46713,890
Net Income
Net income
1,945
2,394
4,422
6,036
11,400
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
7.71
9.49
17.50
23.88
45.11